Neumora Therapeutics (NMRA) Payables (2022 - 2026)
Neumora Therapeutics (NMRA) reported Payables of $4.15 million for Q2 2026, up 543.9% from $644,000 a year earlier but down 18.0% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Payables (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics posted Payables of $3.38 million, up 2.2% from FY2024.
- Payables has a three-year compound annual growth rate of -22.1% (FY2022 to FY2025).
- By year, Payables came in at $3.31 million in FY2024 (+881.3%), $337,000 in FY2023 (-95.3%) and $7.15 million in FY2022.
- Five-year quarterly Payables spans a low of $337,000 in Q4 2023 and a high of $7.15 million in Q4 2022.
- Year over year, Payables has now increased in each of the last three quarters, with growth averaging 227.6% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q4 2024 (growth of 881.3%); the low point was Q4 2023 (a decline of 95.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.06 million (Q1 2026), $3.38 million (Q4 2025) and $549,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Neumora Therapeutics | 88.31 Mn | -529.65 Mn | - | 4.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.15 Mn |
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 35.86 Mn |
| Jun 30, 2025 | 644,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 337,000.00 |
| Sep 30, 2023 | 2.23 Mn |
| Dec 31, 2022 | 7.15 Mn |
API Access
Neumora Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();